EFFICACY OF HMG-CoA REDUCTASE INHIBITORS IN COVID-19 PATIENTS MORTALITY RATE: A META-ANALYSES OF RANDOMIZED CONTROL TRIALS

EFFICACY OF HMG-CoA REDUCTASE INHIBITORS IN COVID-19 PATIENTS MORTALITY RATE: A META-ANALYSES OF RANDOMIZED CONTROL TRIALS

AIM: This study aims to evaluate the efficacy of HMG-CoA reductase inhibitors in the mortality of patients with Covid-19 BACKGROUND: The sudden emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 2019 sparked a pandemic of coronavirus disease 2019 (COVID-19), leading to...

Full description

Bibliographic Details
Main Authors: Mohammadreza Shafiei, Mohammadamin Keykhah
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Journal of Global Antimicrobial Resistance
Subjects:
COVID-19
HMG-CoA REDUCTASE INHIBITORS
STATINS
META-ANALYSES
Online Access:http://www.sciencedirect.com/science/article/pii/S2213716524004211

Internet

http://www.sciencedirect.com/science/article/pii/S2213716524004211

Similar Items